Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Tumor necrosis factor-alpha Stories

2013-05-15 23:30:34

Observational Study by Neurological Wellness Center Physicians Confirms Significant Recoveries with Perispinal Etanercept Administered Years After the Injury. (PRWEB) May 15, 2013 Neurological Recovery Guide and Neurological Wellness Center have been facilitating recovery from TBI since 2010.This research published in the Journal BMC Neuroscience and available online finds; "The TBI induced cerebral ischemia, neurological motor deficits,and increased numbers of microglia-TNF-alpha double...

2013-05-15 00:21:05

Comprehensive SARIL-RA development program to include 2,600 patients in four Phase 3 and one open-label extension trials PARIS and TARRYTOWN, N.Y., May 15, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the COMPARE and ASCERTAIN trials of sarilumab, the first fully human monoclonal antibody directed against the IL-6 receptor, which is delivered by subcutaneous injection every other week, have enrolled...

2013-04-10 23:03:44

The 14-minute segment that aired on 60 Minutes Australia features a man, Charlie Giales, with severe Alzheimer´s receiving a perispinal injection of the drug Enbrel. Within minutes of receiving this injection, Charlie regains his mental faculties. (PRWEB) April 10, 2013 This 60 Minute show, which aired October 16, 2011, powerfully demonstrates that Alzheimer´s disease no longer has to be the long good-bye that it was for Ronald Reagan. Substantial recovery of memory and...

2013-03-18 20:57:34

Results showing the same signaling enzymes can trigger two different processes in the cell sound a warning to biomedical researchers Stroke, heart attacks and numerous other common disorders result in a massive destruction of cells and tissues called necrosis. It´s a violent event: As each cell dies, its membrane ruptures, releasing substances that trigger inflammation, which in turn can cause more cellular necrosis. A new Weizmann Institute study may help develop targeted therapies...

New Target For Rheumatoid Arthritis Identified By Researchers
2013-01-25 14:50:37

Hospital for Special Surgery Researchers at Hospital for Special Surgery have identified a potential new target for drugs to treat patients with rheumatoid arthritis (RA), a protein known as IRHOM2. The finding could provide an effective and potentially less toxic alternative therapy to tumor necrosis factor-alpha blockers (TNF-blockers), the mainstay of treatment for rheumatoid arthritis, and could help patients who do not respond to this treatment. Efforts to develop drugs that hone in...

2013-01-24 13:44:54

With a desire to inhibit metastasis, Cornell biomedical engineers have found the natural switch between the body's inflammatory response and how malignant breast cancer cells use the bloodstream to spread. (PLOS ONE, Jan. 23, 2013) Pro-inflammatory signaling molecules in blood called cytokines constitute a "switch" that induces the mechanism by which breast cancer cells "roll" and adhere to the blood vessel surface. The cancer cells eventually stick to the vessel and infiltrate it. The...

2013-01-10 05:00:31

Neurological Wellness Center utilizes the drug Enbrel in an off-label manner to induce dramatic and sustained recovery of physical and cognitive function in individuals affected by Alzheimer´s disease, stroke and traumatic brain injury. Neurological Wellness Center, http://www.neurological-recovery-guide.com, and Enbrel Buyer´s Club, http://www.genuine-enbrel-cheaper.com, have entered into a partnership to give consumers up to a 40% price discount on boxes of Enbrel. Harmony,...

2013-01-03 05:00:56

An observational study involving 629 subjects finds rapid, significant, readily-observable improvement in stroke and traumatic brain injury patients following the perispinal administration of Enbrel. (PRWEB) January 02, 2013 Neurological Wellness Center began holding perispinal injection technique training courses in the spring of 2011. Since then physicians, nurses and lay caregivers have come from around the world to their Center in Managua Nicaragua for individualized instructional...

2012-12-20 05:00:35

The Perispinal Enbrel Injection Procedure that Dramatically Reverses the Cognitive Deficits and Physical Impairments Caused by Alzheimer´s Disease, Stroke and Traumatic Brain Injury is Now Available in a $49 On-Line Course Offered by http://www.neurological-recovery-guide.com (PRWEB) December 19, 2012 Neurological Wellness Center began holding perispinal injection technique training courses in the spring of 2011. Since then physicians, nurses and lay caregivers have come from around...

2012-11-27 04:21:13

LEXINGTON, Mass., Nov. 27, 2012 /PRNewswire/ -- Avaxia Biologics, Inc., a privately-held biotechnology company developing oral antibody drugs that act locally within the digestive tract, announced today that the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for AVX-470 for the treatment of ulcerative colitis. AVX-470 is an anti-TNF polyclonal antibody and is the first clinical candidate to come from Avaxia's oral antibody platform. The...